(c) 2024 PillSync.com

pregabalin 300 MG Oral Capsule

1 INDICATIONS AND USAGE Pregabalin capsules are indicated for: • Management of neuropathic pain associated with diabetic peripheral neuropathy • Management of postherpetic neuralgia • Adjunctive therapy for the treatment of partial-onset seizures in patients 17 years of age and older • Management of fibromyalgia • Management of neuropathic pain associated with spinal cord injury Pediatric use information is approved for Pfizer's LYRICA (pregabalin) Capsules and Oral Solution products. However, due to Pfizer's marketing exclusivity rights, this drug product is not labeled with that pediatric information. Pregabalin capsules are indicated for: • neuropathic pain associated with diabetic peripheral neuropathy (DPN) (1 ) • Postherpetic neuralgia (PHN) (1) • Adjunctive therapy for the treatment of partial-onset seizures in patients 17 years of age and older ( 1) • fibromyalgia ( 1) • neuropathic pain associated with spinal cord injury (1 )

major pharmaceuticals


4 years ago CAPSULE RED LA 48 pregabalin 300 MG Oral Capsule

CAPSULE RED LA 48

4 years ago CAPSULE RED LA 48 pregabalin 300 MG Oral Capsule

LA 48 CAPSULE RED

16 HOW SUPPLIED/STORAGE AND HANDLING 25 mg capsules: white opaque/white opaque size "4" hard gelatin capsules imprinted with "LA" on cap and "41" on body with black ink, filled with white to off-white granular powder; available in: Carton of 30 capsules (10 capsules each blister pack x 3) NDC 0904-6991-04 Carton of 100 capsules (10 capsules each blister pack x 10) NDC 0904-6991-61 50 mg capsules: white opaque/white opaque size "3" hard gelatin capsules imprinted with "LA" on cap and "42", black band on body with black ink, filled with white to off-white granular powder; available in: Carton of 100 capsules (10 capsules each blister pack x 10) NDC 0904-6992-61 75 mg capsules: red opaque/white opaque size "4" hard gelatin capsules imprinted with "LA" on cap and "43" on body with black ink, filled with white to off-white granular powder; available in: Carton of 100 capsules (10 capsules each blister pack x 10) NDC 0904-7000-61 100 mg capsules: red opaque/red opaque size "3" hard gelatin capsules imprinted with "LA" on cap and "44" on body with black ink, filled with white to off-white granular powder; available in: Carton of 100 capsules (10 capsules each blister pack x 10) NDC 0904-7001-61 150 mg capsules: white opaque/white opaque size "2" hard gelatin capsules imprinted with "LA" on cap and "45" on body with black ink, filled with white to off-white granular powder; available in: Carton of 100 capsules (10 capsules each blister pack x 10) NDC 0904-7002-61 200 mg capsules: orange opaque/orange opaque size "1" hard gelatin capsules imprinted with "LA" on cap and "46" on body with black ink, filled with white to off-white granular powder; available in: Carton of 30 capsules (10 capsules each blister pack x 3) NDC 0904-7003-04 225 mg capsules: orange opaque/white opaque size "1" hard gelatin capsules imprinted with "LA" on cap and "47" on body with black ink, filled with white to off-white granular powder; available in: Carton of 30 capsules (10 capsules each blister pack x 3) NDC 0904-7004-04 300 mg capsules: red opaque/white opaque size "0" hard gelatin capsules imprinted with "LA" on cap and "48" on body with black ink, filled with white to off-white granular powder; available in: Carton of 30 capsules (10 capsules each blister pack x 3) NDC 0904-7005-04 Storage and Handling Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F). [See USP Controlled Room Temperature.] Dispense in tight container.


More pills like CAPSULE LA 48

Related Pills

pregabalin 200 MG Oral Capsule

major pharmaceuticals

pregabalin 75 MG Oral Capsule

major pharmaceuticals












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site